KNOWLEDGE BANK

Interviews

Interpharm Consultancy

Founder
Interpharm Consultancy has been providing advice about the UK generic market and consultancy services to generic manufacturers and distributors

Articles

Determinants of Antimicrobial Resistance (AMR) Research in South East Asia

In the year Alexander Fleming made an outstanding medical history by discovering penicillin which helped to combat numerous deadly infections which previously had serious consequences upon human lives

Research Insights

Knowledge integration using product R&D outsourcing in biotechnology

Abstract We build on systems integration literature to explain how and why knowledge integration of nonmodular products is based on a strategic choice between internalizing and outsourcing core RD The underresearched choice of outsourcing core RD on an ongoing basis appears to face risks of higher transactions costs and loss of control We illuminate t

Case Studies

Heat Stable Hepatitis B vaccine

Partner Since Arecor has collaborated with PATH an international global health nonprofit organisation on the development of heat stable vaccines using the ArestatT technology Stabilisation of hepatitis B vaccine one of the many vaccines successfully st

Techno Trends

SKYTROFA® (Lonapegsomatropin-tcgd), The First Therapy Discovered for Pediatric Growth Hormone Deficiency

Acendis Pharma discovered SKYTROFA lonapegsomatropintcgd for the treatment of pediatric growth hormone deficiency It is the only onceweekly treatment applicable for patients with one year of age and older weighing at least kg having lack of growth due to insufficient secretion of endogenous

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Boosting NICU Safety

Norhan Attia

Norhan Attia, clinical pharmacist with five years' experience at Assiut University Hospital, Egypt, specialising in Neonatal Intensive Care. Expert in medication reviews, IV admixtures, and optimising pharmacotherapy outcomes. Currently a dedicated teaching assistant, focusing on pharmaceutical education and enhancing medication safety in NICU settings.

2

Syringe-like Bacterial Nanomachine Emerges as Potential Therapeutics Delivery Device

Chanchal Kumawat

I am Chanchal Kumawat. I started my journey in science as Ph.D. student at Regional Centre for Biotechnology and continued as postdoctoral fellow at Max Perutz labs, Austria.  I enjoyed making scientific discoveries in the laboratory and now, enjoy communicating it as a science writer.

 

3

Innovative Approaches for Safer and More Effective Healthcare

Dani

Dani is a content strategist passionate about crafting compelling narratives. With a knack for blending creativity and data-driven insights, she specialises in developing content that engages and converts.

4

Navigating Regulatory Frameworks: “Generic Approvals in Latin America’s Two Giants- Brazil & Mexico

Bhavya Sridevi Sundaraneedi

Sundaraneedi Bhavya Sridevi is a Master’s student of Regulatory Affairs at National Institute of Pharmaceutical Education and Research (NIPER- Raebareli). She had a six-month internship experience at Hetero Labs in Regulatory affairs of Latin America. Her interests include global regulatory affairs and Latin American emerging market regulations.

Dr. Rahul Shukla

Dr. Rahul Shukla, Assistant Professor at the Department of Pharmaceutics, NIPER Raebareli, Lucknow, an Institute of National Importance, under the Ministry of Chemicals & Fertilizers, Govt. of India. He was awarded SERB International Research Experience (SIRE) Fellow. Listed in Stanford University's Top 2% Scientists in Pharmaceutical Sciences Worldwide. 
Research Interest: Pharmaceutics, Nanomedicine, Particle Engineering, Bionanomaterials for various therapeutic applications.
 

5

Nanoemulsion - A Promising Nanocarrier for Dermal Drug Delivery in Psoriasis

Sindhoor S M

Sindhoor S M is currently working as an Assistant Professor in the Department of Pharmaceutics at Sri Adichunchanagiri College of Pharmacy, Mandya, Karnataka. His areas of specialisation include nanotechnology-based drug delivery system, lipid-based formulations, Topical delivery and gastroretentive in situ gel systems. He has published eight papers based on nanotechnology and lipid-based drug delivery system in peer reviewed indexed journals. Presently he is involved in the development of lipid-based delivery systems.

 

Marina Koland

Marina Koland, is Professor and Head of the Department of Pharmaceutics at the NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore. Her area of specialisation in research is mucoadhesive and nanoparticulate drug delivery. She has published 50 research papers in peer reviewed journals, presented papers at 10 National and 3 International Conferences and worked on several Nitte University funded projects. She is currently working on solid lipid nanoparticles and micelles as drug carriers for targeting.

 

press releasesRead more...

Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

Roche SIX RO ROP OTCQX RHHBY announced today the grand opening of the Roche Genentech Innovation Center Boston expanding Roche and Genentechs US research presence in one

Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)

Ultragenyx Pharmaceutical Inc NASDAQ RARE today announced that the US Food and Drug Administration FDA granted standard full approval of FAYUVI rebisufligene etisparvovechopf

Tenthpin Launches AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru

Switzerland based Tenthpin Management Consultants a global leader in management and technology consulting for Life Sciences companies has announced the launch of Innovation Hub in Bengaluru

Novo and Anthropic will collaborate to advance drug discovery with Claude

Novo Nordisk and Anthropic today announced a collaboration that will help Novo accelerate the development of new medicines and advance AIdriven software development

Leqembi® Pen subcutaneous formulation approved in Japan

BioArctic AB publs Nasdaq Stockholm BIOA B partner Eisai announced today that the subcutaneous autoinjector formulation of Leqembi known as Leqembi Pen in Japan has been approved as a new route of administration for the treatment of early Alzheimers disease

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

Twist Bioscience Corporation NASDAQ TWST a midcap growth and value biotech company today announced an agreement with Lilly TuneLab a collaborative AIML drug discovery platform created by Eli Lilly and Company

EventsRead more...

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

LATEST NEWSRead more...

Dualitas Therapeutics and Roche Partner to Discover Bispecific Antibodies for I&I Diseases

Dualitas Therapeutics has announced a research collaboration and licence agreement with Roche to discover and develop novel bispecific antibody BsAb therapies for immunology and inflammation II diseases

Eisai and Biogen Receive Approval for LEQEMBI Pen for Early Alzheimer’s Disease

Eisai and Biogen have received approval in Japan for LEQEMBI Pen a subcutaneous SC formulation of lecanemab for the treatment of early Alzheimers disease AD

QurCan Therapeutics Enters into Collaboration with Lilly Advance Nucleic Acid Therapies for Nervous System Diseases

QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop nucleic acid therapies for diseases affecting the central nervous system CNS and peripheral nervous system PNS

BostonGene Expands Collaboration with Dana-Farber Cancer Institute for Breast Cancer Research

BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in breast cancers associated with BRCA and BRCA mutations

Telix Receives Approval for Pixclara for Brain Cancer Imaging

Telix Pharmaceuticals has received approval from the US Food and Drug Administration FDA for Pixclara floretyrosine F or FFET a radioactive diagnostic drug used with positron emission tomography PET to image gliomas a type of brain cancer

Evonik Expands Biotechnology Manufacturing Capacity in Slovakia

Evonik has started construction of a biotechnology expansion at its Fermas site in Slovensk upa Slovakia